Submission Information

ABSTRACTS

Key Dates

Abstract Submissions  OPEN Abstract Submissions Close January 8, 2026

Why Present at ISCT?

Delegates networking at posters
Oral presentation session
ISCT audience and stage
Conference moments

Translational
& Global

Share basic research, clinical investigations, manufacturing, regulatory, and commercialization work with the global CGT community.

Showcase
& Collaborate

Oral presentations, elevator pitches, or poster presentations offer the opportunity to expand your professional network and put your research in front of key opinion leaders, potential collaborators, and future employers.

Launch
Your Career

ISCT is invested in the future of our sector and has created exclusive opportunities for Early Stage Professionals to present their work at ISCT 2026. Students, recent grads, and postdocs are encouraged to submit.

Publish
Your Work

Accepted abstracts are published in a special supplemental edition of Cytotherapy, the official journal of ISCT, spotlighting your research to a global audience.

Awards & Recognition

Abstract Awards across multiple categories will be available to support the attendance and participation of abstract submitters across the many disciplines of our field.

  • 41 Awards at ISCT 2025
  • Prizes totaling $40,000+ USD

ISCT 2026 Abstract Awards - Details Coming Soon

Showcase
& Collaborate

300+ Speaking Opportunities

Oral presentations, elevator pitches, and poster presentations are prime opportunities to put research in front of key opinion leaders, potential collaborators, and future employers.

Visibility & Impact

Present to an international audience across the academic, industry, and regulatory sectors; increase the visibility of your work, and drive impact across the CGT ecosystem.

Poster Hall
ISCT 2026 Dublin will feature a large Poster Hall open to delegates throughout the meeting. In addition, ISCT 2026 will host two dedicated poster networking receptions during which all meeting delegates gather in the Poster Hall to review research, discuss findings and network with presenters.
Oral Presentations
High-scoring abstracts will be invited to give a 10-minute presentation of their work at one of many oral abstract sessions. In total, 100 Oral Presentations will be featured. These sessions are well-attended, attracting over 200 delegates each.
Elevator Pitch
The highest scoring abstracts that opt-in for Elevator Pitch presentations will be invited to compete for the Best Elevator Pitch Award. Presenters will have 2 minutes to summarize their research and its impact on the field.
ISCT 2026 Abstract Categories
  • Mesenchymal Stem/Stromal Cells
  • Hematopoietic Stem/Progenitor Cells and Engineering
  • Immunotherapy (CAR-T, T Reg, NK Cells etc.)
  • Exosomes/EVs
  • iPSC
  • Gene Editing/Gene Therapies (CRISPR, TALENs, ZFNs, AAVs, LNPs, nucleotide-based therapies etc.)
  • Tissue Engineering
  • Embryonic, Organ and Other Tissue Specific Stem Cells
  • Process Development and Manufacturing
  • Regulatory Affairs and Quality Systems
  • Patient Perspective, Workforce Development, CGT Infrastructure
ISCT 2026 Abstract Awards
  • Top Scoring Abstract Award (x1, $1500 USD)
  • Best Poster Award (x1, $1500 USD)
  • Best Elevator Pitch Abstract Award (x1, $1000 USD)
  • Early-Stage Professionals Awards (x3, $1000 USD each)
  • Technologist Awards (x3, $1000 USD each)
  • Top Scoring Emerging Economies Abstract Award (x1, $1000 USD)
  • Host Country Abstract Travel Awards at Annual Meeting (x4 Ireland, x4 United Kingdom/Europe, $1000 USD each)
  • Top Scoring Australia and New Zealand Abstract Award (x1, $1000 USD)
  • Top Scoring North America Abstract Award (x1, $1000 USD)
  • Top Scoring Asia Abstract Award (x1, $1000 USD)
  • Top Scoring South and Central America Abstract Award (x1, $1000 USD)
  • Top Scoring Start-Ups Awards (x2 each for one Enabler and one Developer, $1000 USD)
  • Top Scoring Automation & Artificial Intelligence Award (x1, $1000 USD)
  • Top Scoring iPSC Abstract Award (x1, $1000 USD)
  • Top Scoring Exosomes Abstract Award (x1, $1000 USD)
  • Top Scoring In vivo Gene Editing Award (x1, $1000 USD)

ABSTRACT AWARD GENERAL ELIGIBILITY CRITERIA

Current 2026 Membership

Recipient must hold current 2026 ISCT membership.

Present In-Person

Recipient must present the abstract in-person at ISCT 2026 Dublin.

One Award Per Recipient

Recipient cannot win multiple awards.

*Additional information and a full list of available awards to be announced shortly

General Guidelines
  • ISCT membership is not required to submit and present an abstract.
  • The abstract body cannot exceed 2,500 characters, exclusive of the title, author block, images, and tables.
  • Note that spaces count as characters.
  • Ensure that any references to licensed products are labelled with their non-proprietary names.
  • Abstracts must be submitted via the online Abstract Submission System. Abstracts will not be accepted by email, mail, or fax.
  • There are limited opportunities for oral talks. Invitations to give an oral presentation are based on the quality and scope of the submitted abstract as determined through our blinded-review process.
  • The inclusion of all relevant data to your topic is strongly encouraged as Reviewers will evaluate this when scoring submitted abstracts.
  • ISCT may reject abstracts that are considered inappropriate for any reason. Abstracts, once submitted, can only be withdrawn no later than February 24, 2026. If not withdrawn by this deadline, all accepted abstracts will be published in the final program and abstract supplement.
  • Abstract presenters must have full conference registration to present at the meeting.
  • All accepted abstracts are subject to the ISCT Embargo Policy until 23:59 EDT April 28, 2026.
Embargo Policy
  • Abstracts submitted to the ISCT 2026 Dublin Annual Scientific Meeting are embargoed from the time of submission until 23:59 EDT April 28, 2026.
  • To be eligible for presentation, information within the abstract (and additional data to be presented) may not be published elsewhere or made public before the abstract has been published/presented at the ISCT 2026 Annual Scientific Meeting.
  • Authors must notify ISCT if, after the submission deadline, the submitted abstract is accepted for publication elsewhere and will be published before the meeting. Publication before the meeting may result in the abstract being removed from the conference.
  • If the Embargo Policy is violated, the abstract may be withdrawn by ISCT from presentation and from publication in the abstract supplement.

* An embargo means that information from any abstract or presentation may not be announced, publicized, or distributed before the embargo date and time.

Encore Abstract Policy
  • ISCT generally does not accept encore abstracts unless there are substantial data updates.
  • Exceptions may be granted upon written request to jan@isctglobal.org, with a clear justification for the encore abstract (e.g., if the ISCT audience significantly differs from the initial presentation).

* An encore abstract is the resubmission of an original abstract that has previously been presented at another conference.